They’d watched nervously as invasive Aedes mosquito species that can carry the virus ... approved vaccine is authorized only ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

So far this year, authorities have identified at least 13 cases of locally acquired dengue, up from two in 2023, with two in ...

Transgene, ProBioGen join forces to advance individualized cancer vaccine development: Strasbourg, France Thursday, November 7, 2024, 11:00 Hrs [IST] Transgene, a biotech company ...

myvac is a viral vector (MVA—Modified Vaccinia Ankara ... This virus-based therapeutic vaccine encodes neoantigens (patient-specific mutations) identified and selected by NEC’s Neoantigen Prediction ...

and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its ...

The context: Mosquito-borne viral illnesses ... But the only FDA-approved vaccine is authorized only for children in narrow ...

The MVA-VLP derived vaccines elicit durable immune responses in the host similar to a live-attenuated virus, while providing ...

Over 17,000 malaria cases emerge within 2 weeks; doctors discourage frequent painkillers due to effects on kidneys.

Advanced BioScience Laboratories (ABL), a biotherapy, oncolytic and viral vector contract development ... dedicated to advancing therapeutics, vaccines, and other biological products. With over 60 ...

Vaccitech's six products are all in early stage trials or pre-clinical testing, and are all based on the viral vector vaccine technology. The vaccines can be used as treatment or prophylaxis ...